Facebook
X
LinkedIn
ForwardMiami Cancer Institute Immunotherapies Summit for Hematologic Malignancies, Seventh Annual
Agenda
Friday, March 6 | 6.25 Cat. 1
| 7:30 - 8:30 a.m. | Breakfast & Visit Exhibits- Product Theater (BMS) |
| 8:30 - 8:45 a.m. | Welcome and Introductions Guenther Koehne, M.D., Ph.D. |
| Multiple Myeloma | |
| 8:45 - 9:05 a.m. | Maintenance Therapy Post Autologous Transplants: Does MRD status Affect the Treatment Choice? Saad Usmani, M.D. |
| 9:05 - 9:25 a.m. | Redirecting Therapies for Relapse/Refractory Multiple Myeloma by CAR T and Bites Adam Cohen, M.D. |
| 9:25 - 9:45 a.m. | Integration of CellMods into Treatment Approaches for Multiple Myeloma Paul Richardson, M.D. |
| 9:45 - 10:05 a.m. | Insights on Adapting Treatments for Multiple Myeloma with New Immunotherapies in Countries with Limited or Intermediate Resources Patricio Duarte, M.D. |
| 10:05 - 10:25 a.m. | How to Treat AL Amyloidosis in 2026 Heather Landau, M.D. |
| 10:25 - 10:45 a.m. | Panel Discussion Usmani, Cohen, Richardson, Duarte, Landau |
| 10:45 - 11:05 a.m. | Break and Visit Exhibits |
| B- and T-Cell Malignancies | |
| 11:05 - 11:25 a.m. | Novel Therapies in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) Matthew Matasar, M.D. |
| 11:25 - 11:45 a.m. | Novel therapies in Chronic Lymphocytic Leukemia (CLL) Craig Sauter, M.D. |
| 11:45 - 12:05 p.m. | Overcoming Treatment Resistance in T-All: Translation to the Clinic Wendy Stock, M.D. |
| 12:05 - 12:20 p.m. | Panel Discussion Matasar, Sauter, Stock |
| 12:20 - 12:50 p.m. | Lunch and Exhibits |
| 12:50 - 1:20 p.m. | Product Theater (J&J) |
| Acute Leukemia | |
| 1:20 - 1:40 p.m. | AML 2026: Is 7+3 Still The Standard of Care? Richard Stone, M.D. |
| 1:40 - 2:00 p.m. | Updates on Targeted Therapies in Acute Myeloid Leukemia Eytan Stein, M.D. |
| 2:00 - 2:20 p.m. | LYT-200 An Anti-Galectin 9 Antibody, for Treatment of AML/High-risk TBD |
| 2:20 - 2:35 p.m. | Panel Discussion Stone, Stein |
| 2:35 - 2:50 p.m. | Break and Visit Exhibits |
| Myeloproliferative Disorders | |
| 2:50 - 3:10 p.m. | Novel Therapeutic Strategies in Myelofibrosis Raajit K. Rampal, M.D., Ph.D. |
| 3:10 - 3:30 p.m. | The Role of Menin Inhibitors in Myelofibrosis Firas El Chaer, M.D. |
| 3:30 - 3:50 p.m. | Myelofibrosis: Who to Transplant and Who Not to Transplant? Nicolaus Kroeger, M.D. |
| 3:50 - 4:05 p.m. | Panel Discussion Rampal, El Chaer, Kroeger |
| 4:05 - 4:15 p.m. | Closing Remarks/Adjourn Guenther Koehne, M.D., Ph.D. |
Saturday, March 7 | 4.25 Cat. 1
| 8:00 – 8:30 a.m. | Registration and Breakfast, Visit Exhibits and Product Theater (Incyte) |
| Updates on CAR Therapies | |
| 8:30 – 8:50 a.m. | Next Steps in CAR T-Cell Therapies TBD |
| 8:50 – 9:10 a.m. | Optimizing CAR T-Cell Homing via GPS Robert Sackstein, M.D., Ph.D. |
| 9:10 – 9:30 a.m. | Do CARs Always Have to be T-Cells? Paul Lin, M.D. |
| 9:30 – 9:50 a.m. | The Role of Intestinal Microbiome in Cancer Immunotherapy TBD |
| 9:50 – 10:05 a.m. | Panel Discussion Sackstein, Lin |
| 10:05 – 10:20 a.m. | Break, Visit Exhibits |
| 10:20 – 10:50 a.m. | Product Theater (Pfizer) |
| Allogeneic Stem Cell Transplants | |
| 10:50 – 11:10 a.m. | Myelodysplastic Syndrome (MDS): Who to Transplant and Who Not to Transplant? Mary M. Horowitz, M.D. |
| 11:10 – 11:30 a.m. | Novel Insights in the Development of Acute GVHD Alan Hanash, M.D. |
| 11:30 – 11:50 a.m. | Novel Approaches to GVHD Prevention and Therapy Corey Cutler, M.D. |
| 11:50 – 12:05 p.m. | Panel Discussion Saber, Hanash, Cutler |
| 12:05– 12:20 a.m. | Break and Visit Exhibits |
| 12:20 – 12:40 p.m. | Donor and Graft Source Optimization for Allo Transplant Robert Soiffer, M.D. |
| 12:40 – 1:00 p.m. | Redifining Preventation - What’s Next for GVHD Prophalaxis? Leo Luznik, M.D. |
| 13:00 – 1:20 p.m. | Is it time for post-transplant maintenance therapies in AML? Guenther Koehne, M.D., Ph.D. |
| 1:20 – 1:35 p.m. | Panel Discussion Soiffer, Luznik, Koehne |
| 1:35 – 1:45 p.m. | Closing Remarks and Adjourn |
NOTE: Schedule subject to change.
JW Marriott Miami
1109 Brickell Avenue
Miami, Florida 33131
United States
+1 (305) 329-3500
About the Venue
The JW Marriott Miami is located in the heart of Brickell, Miami's trendy destination for dining, shopping, and nightlife and is located a short walk away from the popular shopping and entertainment destination, Brickell City Centre. Guests are not far from all that Miami has to offer including the Perez Art Museum, Frost Science Museum, Kaseya Center (home of the Miami Heat), Adrienne Arsht Center, Port of Miami, South Beach, Coral Gables, Coconut Grove and Miami International Airport.
Rooms Rates and Highlights
- 399.00 USD per night - Last Day to Book: Thursday, February 12, 2026
- 24-hour room service - Free Wi-Fi for Marriott Bonvoy members - Complimentary fitness center access - Spa - Pool - Business Center
Travel Information
The drive time between the JW Marriott Miami and Miami International Airport (MIA) is around 20 minutes and covers a distance of around 8.2 miles.
Services + Amenities
Relax with a facial or full body massage by an expert therapist at Salus Spa. Afterward, continue to unwind in the warmth of the Miami sun at the JW Marriott Miami's stainless steel sky pool.
Adjacent to The Spa is our Fitness Studio, the perfect escape for an energizing workout, featuring state-of-art equipment and free weights.
Dining
Isabela's
With its natural light and views of Brickell Ave, Isabela's is the perfect place to start the day.
La Terraza Cafe & Bar
With its Plasma TV's and LED Screens tuned to popular sporting events & delicious casual fare served at lunch, dinner, and weekend Brunch makes La Terraza the ideal place to unwind with friends and family.
Downtown Miami and Brickell
Greater Miami is synonymous with beautiful beaches and towering palm trees - but in its urban center, it is the cityscape of glittering skyscrapers over Biscayne Bay that gets all the attention. Diverse, dynamic and densely populated, Downtown Miami and the adjoining Brickell area is a hub of international finance, dining, arts and entertainment that no visitor should miss.
Symposium Director
Deputy Director and Chief of Stem Cell Transplantation
Hematologic Oncology
Baptist Health, Miami Cancer Institute
Miami, Florida
Faculty
Associate Professor of Medicine
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania
Medical Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts
Associate Professor of Hematology
Instituto Universitario CEMIC
Bueno Aires, Argentina
Chief of Leukemia and
Medical Director of Infusion
Baptist Health, Miami Cancer Institute
Miami, Florida
Oncologist
Memorial Sloan Kettering Cancer Center
New York
Professor of Medicine
Medical Director of the Department of Stem Cell Transplantation
University Medical Center
Hamburg-Eppendorf
Hamburg, Germany
Hematology Oncology
Bone Marrow Transplant Specialist and Cellular Therapists
Memorial Sloan Kettering Cancer Center
New York, New York
Assistant Professor of Medicine
Multiple Myeloma and Cellular Therapy
MD Anderson Cancer Center
Houston, Texas
Chief of Hematology Oncology
Baylor College of Medicine
Houston, Texas
Chief, Division of Blood Disorders
Rutgers CINJ and RWJBarnabas Health
Professor of Medicine, Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey
Associate Member and Clinical Director
Leukemia Service
Memorial Sloan Kettering Cancer Center
New York, New York
Clinical Program Leader and Director of Clinical Research
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
RJ Corman Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Scientific Director, CIBMTR and
Professor of Medicine, Division of Hematology/Oncology
CIBMTR Milwaukee
Medical College of Wisconsin
Tenured – Professor
Department of Cellular and Molecular Medicine
Herbert Wertheim College of Medicine
Florida International University
Miami, Florida
Hematology and Medical Oncology
Medical Director
Memorial Sloan Kettering Cancer Center
New York, New York
Chief, Division of Hematologic Malignancies
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Assistant Attending Physician
Director, Program for Drug Development in Leukemia
Leukemia Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York
Anjuli Seth Nayak
Professor of Leukemia Research
University of Chicago
Chicago, Illinois
Chief of Staff, Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Chief of Myeloma Service at
Memorial Sloan Kettering Cancer Center
Professor at Weill Cornell Medical College
New York, New York
NOTE: Faculty subject to change.
Disclosures And Resolution of Conflict of Interest Disclosure Policy and Disclaimer
Accreditation
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 10.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 10.5 credit hours, Day 1, 6.25 Credit hours - CE Broker Course #20-1358788 and Day 2, 4.25 credit hours - CE Broker Course #20-1358812, by the Florida Boards of Medicine, Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity has been approved for a maximum of 10 credits for Nurse Practitioners, Nurses, Dietitians, Laboratory Personnel and Respiratory Therapists (6 Credit hours - CE Broker Course #20-1358788 and Day 2, 4 credit hours - CE Broker Course #20-1358812) and 10.5 credits for Pharmacists and Techs (6.25 Credit hours - CE Broker Course #20-1358788 and Day 2, 4.25 credit hours - CE Broker Course #20-1358812). Baptist Health South Florida CE Broker Provider #50-182.
The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.
AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Disclaimer
Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.
While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.